Probiotec Ltd
XBER:PG3

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
XBER:PG3
Watchlist
Price: 1.79 EUR -1.65%
Market Cap: €145.6m

Gross Margin

30%
Current
Declining
by 0.3%
vs 3-y average of 30.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
30%
=
Gross Profit
AU$66.3m
/
Revenue
AU$221.2m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
30%
=
Gross Profit
€66.3m
/
Revenue
AU$221.2m

Peer Comparison

Country Company Market Cap Gross
Margin
AU
Probiotec Ltd
ASX:PBP
242.3m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
211.5B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
41th
Based on 2 544 companies
41th percentile
30%
Low
-6 907 100% — 21.6%
Typical Range
21.6% — 58.2%
High
58.2% — 2 095.9%
Distribution Statistics
Australia
Min -6 907 100%
30th Percentile 21.6%
Median 38.3%
70th Percentile 58.2%
Max 2 095.9%

Probiotec Ltd
Glance View

Market Cap
145.6m EUR
Industry
Pharmaceuticals

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The firm subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.

PG3 Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
30%
=
Gross Profit
AU$66.3m
/
Revenue
AU$221.2m
What is Probiotec Ltd's current Gross Margin?

The current Gross Margin for Probiotec Ltd is 30%, which is below its 3-year median of 30.2%.

How has Gross Margin changed over time?

Over the last 3 years, Probiotec Ltd’s Gross Margin has increased from 29.7% to 30%. During this period, it reached a low of 28.7% on Jun 30, 2021 and a high of 31.4% on Jun 30, 2022.

Back to Top